National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)

Funding Agency:
National Institutes of Health

This Notice of Funding Opportunity (NOFO) encourages grant applications for National Centers for Biomedical Imaging and Bioengineering (NCBIB). NCBIB are national resource centers for conducting research and development on new technologies that are driven by the needs of basic, translational, and/or clinical researchers. NCBIB also make their technologies available to other investigators, train members of the research community in the use of the technologies and disseminate the technologies broadly. 


  • Letters of Intent Receipt Date(s): The Letters of Intent are due 8 weeks prior to the September 25, 2023, application due date and 12 weeks prior to all subsequent application due dates.
  • P Series Deadlines: Jan. 25, May 25, Sep. 25.
  • AIDS Deadlines: Jan. 7, May 7, Sep. 7.

PAR-23-235 Expiration Date: September 08, 2026

Agency Website

Eligibility Requirements

An individual applicant may not serve as PD/PI, including Multiple PD/PI, on more than one application to this NOFO at any time.

Amount Description

Direct costs (excluding equipment) are not limited and are expected to vary among applications. Typical direct costs for NCBIB range between $600,000 and $750,000. In addition, up to $500,000 can be requested for special-purpose equipment during a five-year funding period. This budget is restricted only for acquiring special-purpose equipment.  

Support may be requested for up to five years.  Applicants may submit a Renewal application. However, NIBIB NCBIB Awards will be restricted to a total of fifteen years.   

    Funding Type





    Engineering and Physical Sciences
    Medical - Basic Science
    Medical - Clinical Science
    Medical - Translational

    External Deadline

    January 25, 2024